Your browser doesn't support javascript.
loading
Vagus nerve stimulator revision in pediatric epilepsy patients: a technical note and case series.
LoPresti, Melissa A; Huang, Jonathan; Shlobin, Nathan A; Curry, Daniel J; Weiner, Howard L; Lam, Sandi K.
  • LoPresti MA; Division of Pediatric Neurosurgery, Texas Children's Hospital; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA.
  • Huang J; Division of Pediatric Neurosurgery, Lurie Children's Hospital; Department of Neurosurgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Shlobin NA; Division of Pediatric Neurosurgery, Lurie Children's Hospital; Department of Neurosurgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Curry DJ; Division of Pediatric Neurosurgery, Lurie Children's Hospital; Department of Neurosurgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Weiner HL; Division of Pediatric Neurosurgery, Texas Children's Hospital; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA.
  • Lam SK; Division of Pediatric Neurosurgery, Texas Children's Hospital; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA.
Childs Nerv Syst ; 39(2): 435-441, 2023 02.
Article en En | MEDLINE | ID: mdl-36434283
ABSTRACT

INTRODUCTION:

Vagus nerve stimulation (VNS) is an adjunctive treatment in children with intractable epilepsy. When lead replacement becomes necessary, the old leads are often truncated and retained and new leads are implanted at a newly exposed segment of the nerve. Direct lead removal and replacement are infrequently described, with outcomes poorly characterized. We aimed to describe our experience with feasibility of VNS lead removal and replacement in pediatric patients.

METHODS:

Retrospective review examined 14 patients, at a single, tertiary-care, children's hospital, who underwent surgery to replace VNS leads, with complete removal of the existing lead from the vagus nerve and placement of a new lead on the same segment of the vagus nerve, via blunt and sharp dissection without use of electrocautery. Preoperative characteristics, stimulation parameters, and outcomes were collected.

RESULTS:

Mean age at initial VNS placement was 7.6 years (SD 3.5, range 4.5-13.4). Most common etiologies of epilepsy were genetic (5, 36%) and cryptogenic (4, 29%). Lead replacement was performed at a mean of 6.0 years (SD 3.8, range 2.1-11.7) following initial VNS placement. Reasons for revision included VNS lead breakage or malfunction. There were no perioperative complications, including surgical site infection, voice changes, dysphagia, or new deficits postoperatively. Stimulation parameters after replacement surgery at last follow-up were similar compared to preoperatively, with final stimulation parameters ranging from 0.25 mA higher to 1.5 mA lower to maintain baseline seizure control. The mean length of follow-up was 7.9 years (SD 3.5, range 3.1-13.7).

CONCLUSION:

Removal and replacement of VNS leads are feasible and can be safely performed in children. Further characterization of surgical technique, associated risk, impact on stimulation parameters, and long-term outcomes are needed to inform best practices in VNS revision.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Epilepsia / Estimulación del Nervio Vago / Epilepsia Refractaria Tipo de estudio: Guideline Límite: Adolescent / Child / Child, preschool / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Epilepsia / Estimulación del Nervio Vago / Epilepsia Refractaria Tipo de estudio: Guideline Límite: Adolescent / Child / Child, preschool / Humans Idioma: En Año: 2023 Tipo del documento: Article